Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19

 Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19

Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19

Shots:

  • The collaboration leverages Luminostics’ technology and Sanofi’s global distribution network to ensure WW availability of the test, subject to relevant regulatory approvals. The focus of the collaboration is to develop a consumer-based test that can detect the COVID-19
  • Luminostics’ technology utilizes a consumer smartphone’s optics, controlled by an iOS/Android app paired with a reusable adapter, in combination with glow-in-the-dark nanochemistry and signal processing AI. The OTC self-testing solution is expected to be ready before the end of 2020
  • The rapid self-testing solution will eliminate the current need for HCPs or laboratory tests. The collaboration follows Sanofi’s collaboration with GSK for COVID-19 vaccine and initiation of clinical studies evaluating Kevzara and Plaquenil in patients suffering from COVID-19

Click here ­to­ read full press release/ article | Ref: Sanofi | Image: Usine Digitale

Related News: Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine

Sanofi and Regeneron to Initiate the Clinical Program Evaluating Kevzara (sarilumab) in Patients with Severe COVID-19

Sanofi and Regeneron Expand Clinical Program of Kevzara (sarilumab) for the Treatment of COVID-19 Outside the US

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post